ImaRx Therapeutics, Inc.
(NASDAQ:IMRX)|
0.02 0.00 (0.00%) Nov 19 - Close |
|
|
|
- Compare IMRX with:
- View: Line | Candlestick
Company Profile
ImaRx Therapeutics, Inc.
18116 232nd NE
Woodinville, WA 98077
United States - Map
Phone: (520) 770-1259
Fax: (520) 791-2437
Website: www.imarx.com
State of incorporation: Delaware
CEO: Bradford A. Zakes
Employees: 27
Sector: Healthcare
Industry Group: Drugs
Industry: Diagnostic Substances
Biopharma co.devp.therapies for vascular disorders
A biopharmaceutical company commercializing and developing therapies for vascular disorders.
Recent news for IMRX
-
ImaRx Therapeutics Receives NASDAQ Delisting Notification
GlobeNewswire - Oct 17 at 6:00 ET
-
EDGAR Online - Oct 17 at 6:00 ET
-
EDGAR Online - Sep 26 at 2:24 ET
-
IMARX THERAPEUTICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
EDGAR Online - Sep 24 at 5:03 ET
-
ImaRx Therapeutics Divests Urokinase Franchise to Microbix Biosystems
GlobeNewswire - Sep 24 at 5:00 ET
-
EDGAR Online - Aug 26 at 4:15 ET
-
GlobeNewswire - Aug 26 at 4:00 ET
-
IMARX THERAPEUTICS INC Financials
EDGAR Online Financials - Aug 22 at 8:04 ET